Naomi R Lee1, Rachel L Winer2, Stephen Cherne2, Carolyn J Noonan3, Lonnie Nelson3, Angela A Gonzales4, Jason G Umans5,6, Dedra Buchwald3. 1. Department of Molecular Genetics and Microbiology, University of New Mexico, Albuquerque. 2. Department of Epidemiology, University of Washington, Seattle. 3. Elson S. Floyd College of Medicine, Initiative for Research and Education to Advance Community Health, Washington State University, Seattle. 4. Department of Justice and Social Inquiry, School of Social Transformation, Arizona State University, Tempe. 5. MedStar Health Research Institute, Hyattsville, Maryland. 6. Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, District of Columbia.
Abstract
BACKGROUND: High-risk human papillomavirus (hrHPV) causes cervical cancer. In the United States, approximately 40% of women aged 14-59 years from all racial and ethnic groups are infected with HPV, and prevalence typically declines with age. However, American Indian (AI) women are insufficiently sampled to permit a population-specific estimate of hrHPV prevalence. METHODS: Vaginal swabs were self-collected by 698 AI women aged 21-65 years from a tribal community in the Great Plains. We estimated the population prevalence of hrHPV and identified predominant genotypes. RESULTS: The combined prevalence of hrHPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 was 34.8%. HPV-51 (7.6%), HPV-58 (5.3%), HPV-52 (4.3%), HPV-18 (4.3%), and HPV-16 (3.9%) were most prevalent. hrHPV prevalence declined with age, from 42.2% in women aged 21-24 years to 27.9% in women aged 50-65 years. CONCLUSIONS: HPV-51 was the single most prevalent oncogenic genotype. The combined prevalence of hrHPV among AI women in our sample was high, particularly among women aged 50-65 years, for whom hrHPV prevalence was approximately triple that of other races. Cervical cancer screening efforts should be increased, particularly among women from the community aged 30 years and older.
BACKGROUND: High-risk human papillomavirus (hrHPV) causes cervical cancer. In the United States, approximately 40% of women aged 14-59 years from all racial and ethnic groups are infected with HPV, and prevalence typically declines with age. However, American Indian (AI) women are insufficiently sampled to permit a population-specific estimate of hrHPV prevalence. METHODS: Vaginal swabs were self-collected by 698 AI women aged 21-65 years from a tribal community in the Great Plains. We estimated the population prevalence of hrHPV and identified predominant genotypes. RESULTS: The combined prevalence of hrHPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68 was 34.8%. HPV-51 (7.6%), HPV-58 (5.3%), HPV-52 (4.3%), HPV-18 (4.3%), and HPV-16 (3.9%) were most prevalent. hrHPV prevalence declined with age, from 42.2% in women aged 21-24 years to 27.9% in women aged 50-65 years. CONCLUSIONS: HPV-51 was the single most prevalent oncogenic genotype. The combined prevalence of hrHPV among AI women in our sample was high, particularly among women aged 50-65 years, for whom hrHPV prevalence was approximately triple that of other races. Cervical cancer screening efforts should be increased, particularly among women from the community aged 30 years and older.
Authors: Cosette M Wheeler; William C Hunt; Jack Cuzick; Erika Langsfeld; Amanda Pearse; George D Montoya; Michael Robertson; Catherine A Shearman; Philip E Castle Journal: Int J Cancer Date: 2012-06-20 Impact factor: 7.396
Authors: Maria C Bell; Delf Schmidt-Grimminger; Clemma Jacobsen; Subhash C Chauhan; Diane M Maher; Dedra S Buchwald Journal: Gynecol Oncol Date: 2011-03-17 Impact factor: 5.482
Authors: Eileen F Dunne; Allison Naleway; Ning Smith; Bradley Crane; Sheila Weinmann; Jim Braxton; Martin Steinau; Elizabeth R Unger; Lauri E Markowitz Journal: J Infect Dis Date: 2015-06-29 Impact factor: 5.226
Authors: Wendy A Leyden; M Michele Manos; Ann M Geiger; Sheila Weinmann; Judy Mouchawar; Kimberly Bischoff; Marianne Ulcickas Yood; Joyce Gilbert; Stephen H Taplin Journal: J Natl Cancer Inst Date: 2005-05-04 Impact factor: 13.506
Authors: Skyler J Bordeaux; Anthony W Baca; Rene L Begay; Francine C Gachupin; J Gregory Caporaso; Melissa M Herbst-Kralovetz; Naomi R Lee Journal: Curr Oncol Date: 2021-09-24 Impact factor: 3.109